Autor:	Boris V. Afanasyev, L. Stelmah, A. Nekrasova, V. Baykov, M. Popova, I. Tsygankov, Sergey N. Bondarenko, Ivan S. Moiseev, N. Mikhaylova, Kirill V. Lepik, Y. Rogacheva
Rok vydání:	2018
Předmět:	Oncology medicine.medical_specialty business.industry Internal medicine Relapsed refractory Human immunodeficiency virus (HIV) medicine In patient Hematology Nivolumab medicine.disease_cause business
Zdroj:	Annals of Oncology. 29:x20-x21
ISSN:	0923-7534
DOI:	10.1093/annonc/mdy486.011
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c104b98263f05950556c80cdaa0feb8d https://doi.org/10.1093/annonc/mdy486.011 Zobrazit plný text záznamu